C11orf1 FLJ-112AP Blocking Peptide peptide (STJ504083)
SPECIFICATIONS
ImmunogenMid-region epitope synthetic peptide taken within aino acid region 50-100 on human C11orf1 protein
General Information
| Short Description | C11orf1 FLJ-112AP Blocking Peptide is synthetically produced from the 50-100 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Gene Symbol | CFAP68 |
| Gene ID | 64776 |
| Uniprot ID | CFA68_HUMAN |
| Immunogen | Mid-region epitope synthetic peptide taken within aino acid region 50-100 on human C11orf1 protein |
| Immunogen Region | 50-100 |
Additional Info
| Peptide Name | Cilia- And Flagella-Associated Protein 68 |
| Cellular Localisation | CytoplasmCytoskeletonCilium AxonemeFlagellum AxonemeNucleus |
| Alternative Peptide Names | Cilia- And Flagella-Associated Protein 68 proteinCFAP68 proteinC11orf1 protein |
Information sourced from Uniprot.org